Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis

BACKGROUND: Serotonin (5-HT3) receptor antagonists are a class of antiemetic medications often used to prevent nausea and vomiting among patients undergoing chemotherapy, radiotherapy or surgery. However, recent studies suggest that these agents might be associated with increased cardiac harm. To ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Soobiah, Charlene, Antony, Jesmin, Hemmelgarn, Brenda, Moher, David, Hutton, Brian, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702491/
https://www.ncbi.nlm.nih.gov/pubmed/23810058
http://dx.doi.org/10.1186/2046-4053-2-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702491/
https://www.ncbi.nlm.nih.gov/pubmed/23810058
http://dx.doi.org/10.1186/2046-4053-2-46

Ejemplares similares